Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study.

Date publication

avril 2023

Journal

Progress in neuro-psychopharmacology & biological psychiatry

Auteurs

Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel

Tous les auteurs :
Fond G, Faugere M, Boyer L, Peri P, Stephan F, Moliere F, Anguill L, Bennabi D, Haffen E, Bouvard A, Walter M, Samalin L, Llorca PM, Genty JB, Leboyer M, Holtzmann J, Nguon AS, Rey R, Horn M, Vaiva G, Hennion V, Etain B, El-Hage W, Camus V, Courtet P, Aouizerate B, Yrondi A, Lancon C, Richieri R

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37120004

Résumé

Benzodiazepine long-term use (BLTU) is a public health challenge. We lack data on the consequences of LBTU on the trajectory of treatment-resistant depression (TRD).

Mots clés

Addiction, Benzodiazepine, Depression, Depressive disorders, treatment-resistant, Mental health, Psychiatry, Public health

Référence

Prog Neuropsychopharmacol Biol Psychiatry. 2023 04 27;:110779